newsfilter
← Latest News
GlobeNewswire·

ProMIS Neurosciences to Participate in Upcoming Conferences in November

CAMBRIDGE, Mass., Nov. 05, 2026 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (NASDAQ:PMN), a clinical-stage biotechnology company developing antibody therapeutics and vaccines targeting toxic misfolded proteins in